Lyvia Neves Rebello Alves Nolasco
Postdoctoral researcher in human molecular genetics
Postdoctoral researcher and collaborating professor, Núcleo de Genética Humana e Molecular, Universidade Federal do Espírito Santo (UFES), Brazil · PhD in Biotechnology, UFES (2024)
Portrait: Currículo Lattes / CNPq
Lyvia Neves Rebello Alves Nolasco is a postdoctoral researcher at the Núcleo de Genética Humana e Molecular at UFES in Brazil, where she has worked since her master's studies on molecular genetics and disease risk, more recently including cancer epigenetics and environmental exposures.
First author of a 2026 review in Biochimica et Biophysica Acta, General Subjects surveying rapamycin's biology and medicine, from its discovery as an antifungal macrolide through its role as the founding mTOR inhibitor and its clinical and healthspan applications.
Milestones in the Atlas
A selection, not a full bibliography: only papers that meet the Atlas inclusion criteria.
| Year | Evidence | Study |
|---|---|---|
| 2026 | R | Rapamycin across biology and medicine: From molecular mechanisms to clinical and translational frontiers NOL2026 First author of a comprehensive review of rapamycin/mTOR biology, pharmacology and clinical translation. |
Co-authors in the Atlas 1
People with a profile here who share at least one study with Lyvia Neves Rebello Alves Nolasco.
ShowHide
- Iúri Drumond Louro Professor of human and molecular genetics
Every researcher with a profile →
Thank you. That helps us know which pages have been read by someone who knows the work.
Thank you. We will check it and correct the page.
Thank you. Your answer was counted anonymously.